Metagenomi Therapeutics, Inc. (MGX)
NASDAQ: MGX · Real-Time Price · USD
1.350
+0.040 (3.05%)
At close: May 22, 2026, 4:00 PM EDT
1.352
+0.002 (0.15%)
After-hours: May 22, 2026, 7:01 PM EDT
Metagenomi Therapeutics Employees
Metagenomi Therapeutics had 119 employees as of December 31, 2025. The number of employees decreased by 83 or -41.09% compared to the previous year.
Employees
119
Change
-83
Growth
-41.09%
Revenue / Employee
$187,655
Profits / Employee
-$721,748
Market Cap
50.82M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 119 | -83 | -41.09% |
| Sep 30, 2025 | 124 | -83 | -40.10% |
| Jun 30, 2025 | 171 | -57 | -25.00% |
| Mar 31, 2025 | 176 | -61 | -25.74% |
| Dec 31, 2024 | 202 | -34 | -14.41% |
| Sep 30, 2024 | 207 | -16 | -7.17% |
| Jun 30, 2024 | 228 | 28 | 14.00% |
| Mar 31, 2024 | 237 | 37 | 18.50% |
| Dec 31, 2023 | 236 | - | - |
| Sep 30, 2023 | 223 | - | - |
| Jun 30, 2023 | 200 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Gossamer Bio | 162 |
| Xilio Therapeutics | 76 |
| aTyr Pharma | 60 |
| Plus Therapeutics | 28 |
| Quantum BioPharma | 17 |
| MiNK Therapeutics | 15 |
| Instil Bio | 14 |
| Actuate Therapeutics | 12 |
MGX News
- 13 days ago - Metagenomi price target lowered to $9 from $12 at Wells Fargo - TheFly
- 14 days ago - Metagenomi Therapeutics Reports Business Updates and First Quarter 2026 Financial Results - GlobeNewsWire
- 14 days ago - Metagenomi Therapeutics Earnings release: Q1 2026 - Filings
- 14 days ago - Metagenomi Therapeutics Quarterly report: Q1 2026 - Filings
- 4 weeks ago - Metagenomi Therapeutics Proxy statement: Proxy filing - Filings
- 4 weeks ago - Metagenomi Therapeutics Proxy statement: Proxy filing - Filings
- 5 weeks ago - Metagenomi announces publication on MG119-28 - TheFly
- 5 weeks ago - Metagenomi Therapeutics, Inc. Announces Publication in Nature Structural & Molecular Biology Highlighting Proprietary Compact CRISPR Nuclease with Enhanced Genome Editing Efficiency - GlobeNewsWire